Conversely, a study conducted by Shin and colleagues demonstrated that PD-L1 expression was independently associated with shorter survival in patients with metastatic RCC after VEGF-TKI treatment and significantly related to lack of VEGF-TKI responsiveness (p = 0.012) [127]. This evidence concerns the gene VEGFA and renal cell adenocarcinoma.